| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |